Feb 05 (Reuters) - Conmed Q4 EPS USD 1.08.
- Q4 income from operations USD 52.499 million vs. IBES estimate USD 57.5 million
- Q4 net income USD 33.754 million
- Q4 sales USD 345.944 million vs. IBES estimate USD 341 million
- Q4 pretax profit USD 43.642 million vs. IBES estimate USD 48.2 million
- outlook FY adjusted EPS USD 4.25-4.4